Genexine, Inc. (KOSDAQ:095700)
South Korea · Delayed Price · Currency is KRW 2,140.00
-20.00 (-0.93%)
Nov 2, 2026, 3:30 PM KST
Genexine Market Cap
Genexine has a market cap or net worth of 97.33 billion as of October 30, 2026. It is the 27,328th most valuable company in the world and the 1,270th biggest in South Korea. Its market cap has decreased by 58.69% in one year.
Market Cap
97.33B
Enterprise Value
n/a
Revenue
5.81B
Global Rank
Country Rank
#1,270 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since September 15, 2009, Genexine's market cap has decreased from 109.02B to 97.33B, a decrease of -10.73%. That is a compound annual growth rate of -0.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 97.33B | -54.32% |
| Dec 30, 2025 | 213.07B | -12.27% |
| Dec 30, 2024 | 242.86B | -40.82% |
| Dec 28, 2023 | 410.35B | -12.73% |
| Dec 29, 2022 | 470.21B | -67.78% |
| Dec 30, 2021 | 1.46T | -52.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bioneer | 175.77B |
| Helixmith | 170.37B |
| NeoImmuneTech | 155.82B |
| GC Cell | 151.77B |
| Anterogen.Co.,Ltd. | 133.68B |
| MedPacto | 104.54B |
| Vaxcell-Bio Therapeutics | 86.63B |
| iNtRON Biotechnology | 86.19B |